ARCHIVES

Trial In Metastatic Disease To Be Unblinded After Regorafenib Meets Primary Endpoint

This article is from The Cancer Letter archive.

Vol. 34 No. 11 | November 25, 2011

Download PDF Visit The Full Archive

Related Articles

NIH Awards 24 More Grants For Women’s Health Initiative

October 14, 1994

Includes 8-page Business & Regulatory Report.

April 11, 2003

MSK, Fox Chase Volunteer to Limit Their Core Grants To Let Others Grow

June 29, 1990

Long-Term Results Find Cisplatin Improves Survival

May 25, 2007

NTP Board Okays Contract Concepts

July 10, 1981

Hormone Therapy Can Reduce Survival In Men With Heart Problems

August 26, 2011